Sell Biocon, target of Rs 394: IIFL

Published on Mon, Jul 14, 2008 at 14:37 |  Source : Moneycontrol.com

Updated at Mon, Jul 14, 2008 at 14:43  

23553 Investors following Biocon. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

IIFL has recommended a sell rating on Biocon with a target price of Rs 394 in its July 11, 2008 research report. "FY08 was a difficult year for Biocon, with the rupee's appreciation, regulatory intervention in sales of fixed-dose combination (FDC) drugs, and continued slowdown in sales of statins. The current situation suggests that none of these problems are likely to be resolved any time soon: forward contracts on the dollar negate any gains from the rupee's recent depreciation; and it is likely to take a while for FDCs to re-enter the market. Sell target of Rs 394," says IIFL's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

For further details click on attachment......

Attachments : tfp20080711.pdf

  

Trending News

Business News

Apple will give out a free app a week; App Store will update
Nifty level to watch is 5,150; Bank Index upside is modest "Nifty level to watch is 5,150; Bank Index upside is modest "

Team Anna accuses 15 UPA ministers of graft

DB Realty Q4 Cons Net Profit At `20 Cr Vs `8 Cr (YoY)

The latest earning numbers FIRST on CNBC-TV18
Videos

May 25 2012, 22:26

NHPC posts profit amid capacity addition, delay woes

- in Results Boardroom

Interviews

May 25 2012, 22:00 | Source: CNBC-TV18

Petrol hike on soft global levels is short-sighted: Narayan  

May 25 2012, 17:05 | Source: CNBC-TV18

Expect single digit growth in ad revenue in FY13: Sun TV  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!